Overview

Efficacy of iOWH032 in Dehydrating Cholera

Status:
Withdrawn

Trial end date:
2016-05-01

Target enrollment:

Participant gender:

Summary

The primary hypothesis is that administration of iOWH032 to adult and pediatric males and females with acute cholera due to V. cholerae O1 reduces stool output in the first 24 hours significantly more than does the current standard of care.

Phase:

Phase 2

Details

Lead Sponsor:

PATH

Collaborator:

Bill and Melinda Gates Foundation